Ishige, Takashi http://orcid.org/0000-0002-2409-7359
Shimizu, Toshiaki
Watanabe, Kenji
Arai, Katsuhiro
Kamei, Koichi
Kudo, Takahiro
Kunisaki, Reiko
Tokuhara, Daisuke
Naganuma, Makoto
Mizuochi, Tatsuki
Murashima, Atsuko
Inoki, Yuta
Iwata, Naomi
Iwama, Itaru
Koinuma, Sachi
Shimizu, Hirotaka
Jimbo, Keisuke
Takaki, Yugo
Takahashi, Shohei
Cho, Yuki
Nambu, Ryusuke
Nishida, Daisuke
Hagiwara, Shin-ichiro
Hikita, Norikatsu
Fujikawa, Hiroki
Hosoi, Kenji
Hosomi, Shuhei
Mikami, Yohei
Miyoshi, Jun
Yagi, Ryusuke
Yokoyama, Yoko
Hisamatsu, Tadakazu
Funding for this research was provided by:
Ministry of Health, Labour and Welfare (20316729)
Article History
Received: 30 July 2022
Accepted: 28 December 2022
First Online: 11 January 2023
Change Date: 10 February 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00535-023-01965-0
Declarations
:
: Any financial relationships with enterprises, businesses, or academic institutions in the subject matter or materials discussed in the manuscript are listed as follows. (1) Those from which the authors or the authors’ spouse, partner, or immediate relatives have individually received any income, honoraria, or any other types of remuneration: AbbVie, Astellas Pharma, Celgene, Chugai Pharmaceutical, EA Pharma, Janssen Pharmaceutical, JIMRO, Kissei Pharmaceutical, Kyorin Pharmaceutical, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, Nichi-Iko Pharmaceutical, Nobel Pharma, Pfizer, Takeda Pharmaceutical, and UCB Japan. (2) Those from which the authors have received scholarship/research grants: AbbVie, Alfresa Pharma, AstraZeneca, Chugai Pharmaceutical, Daiichi-Sankyo, EA Pharma, EP-CRSU, Janssen Pharmaceutical, JIMRO, Kyorin Pharmaceutical, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, Nippon Kayaku, Pfizer, Taiju Life Social Welfare Foundation, Takeda Pharmaceutical, TERUMO, Vaccination Research Center, and ZERIA Pharmaceutical. (3) Those from which the authors have individually received an endowed chair: AbbVie, EA Pharma, Mitsubishi Tanabe Pharma, and ZERIA Pharmaceutical.